We are live on
!
Find out more
BFM
Boothbay Fund Management Portfolio holdings
AUM
$7.71B
1-Year Est. Return
106.31%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$3.92B
AUM Growth
-$291M
(-6.9%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-17.71%
Top 10 Holdings %
Top 10 Hldgs %
15.03%
Holding
2,149
New
473
Increased
368
Reduced
416
Closed
539
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
X
US Steel
X
|
+$22.8M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$17M |
| 3 |
Humana
HUM
|
+$16.9M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$15M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$58.4M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$46.8M |
| 3 |
Elanco Animal Health
ELAN
|
+$18.6M |
| 4 |
Synopsys
SNPS
|
+$17.6M |
| 5 |
GSK
GSK
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.46% |
| 2 | Technology | 10.81% |
| 3 | Financials | 6.25% |
| 4 | Industrials | 6.24% |
| 5 | Consumer Discretionary | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Fulcrum Therapeutics
FULC
$283M
| $79.2K | ﹤0.01% |
+11,730
| New | +$52K |
|
|
NVACR
1377
DELISTED
NorthView Acquisition Corporation Rights
NVACR
| $78.6K | ﹤0.01% |
900,861
-108
| -0% | -$12 |
|
|
ILPT
1378
Industrial Logistics Properties Trust
ILPT
$584M
| $78.5K | ﹤0.01% |
+16,701
| New | +$54.2K |
|
1379
Summit Therapeutics
SMMT
$10.4B
| $78.3K | ﹤0.01% |
30,000
| – | – |
|
1380
Kopin
KOPN
$769M
| $77.7K | ﹤0.01% |
+38,278
| New | +$54.7K |
|
1381
TScan Therapeutics
TCRX
$47.3M
| $77.5K | ﹤0.01% |
+13,293
| New | +$60.9K |
|
1382
Puma Biotechnology
PBYI
$391M
| $77.5K | ﹤0.01% |
+17,895
| New | +$59.3K |
|
1383
Porch Group
PRCH
$1.82B
| $77K | ﹤0.01% |
+25,000
| New | +$35.1K |
|
|
RWODR
1384
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
| $77K | ﹤0.01% |
700,000
| – | – |
|
1385
Ouster
OUST
$3.22B
| $76.9K | ﹤0.01% |
+10,025
| New | +$52.6K |
|
|
IVAC
1386
DELISTED
Intevac Inc
IVAC
| $76.7K | ﹤0.01% |
+17,745
| New | +$66.2K |
|
|
BRACR
1387
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
| $76.2K | ﹤0.01% |
650,000
| – | – |
|
1388
Iris Energy
IREN
$14.6B
| $75.9K | ﹤0.01% |
10,619
-254,541
| -96% | -$1.09M |
|
1389
C4 Therapeutics
CCCC
$399M
| $75.7K | ﹤0.01% |
+13,400
| New | +$30.6K |
|
1390
Aemetis
AMTX
$107M
| $75.1K | ﹤0.01% |
+14,337
| New | +$67.8K |
|
1391
Bioventus
BVS
$913M
| $74.9K | ﹤0.01% |
+14,219
| New | +$56.3K |
|
1392
AdaptHealth
AHCO
$913M
| $74.6K | ﹤0.01% |
10,229
-5,111
| -33% | -$40.3K |
|
|
AIOT
1393
PowerFleet Inc
AIOT
$548M
| $74.4K | ﹤0.01% |
+21,761
| New | +$48.6K |
|
1394
Shattuck Labs
STTK
$696M
| $74.4K | ﹤0.01% |
+10,436
| New | +$28.5K |
|
1395
Arteris
AIP
$1.48B
| $74.4K | ﹤0.01% |
12,630
-22,862
| -64% | -$129K |
|
|
NEXRW
1396
Nexera Technologies Ltd Warrant
NEXRW
$33.1K
| $73.3K | ﹤0.01% |
24,038
| – | – |
|
1397
ChargePoint
CHPT
$143M
| $72.6K | ﹤0.01% |
+1,550
| New | +$86.7K |
|
|
FSP
1398
Franklin Street Properties
FSP
$48.1M
| $72.5K | ﹤0.01% |
+28,305
| New | +$61K |
|
|
CTV
1399
DELISTED
Innovid Corp.
CTV
| $71.8K | ﹤0.01% |
+47,843
| New | +$61K |
|
1400
Lifecore Biomedical
LFCR
$165M
| $71.3K | ﹤0.01% |
+11,523
| New | +$80K |
|
Similar funds
MAM
SIAU
WRCM
IMCOOI
CCM
PGFC
AMH
SF
Boothbay Fund Management's Q4 2023 Portfolio in Review
As of Q4 2023, Boothbay Fund Management held 2,149 positions worth $3.92B, down 6.9% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boothbay Fund Management withdrew a net $694M in Q4 2023, closing 539 positions and reducing 416 holdings. Its most notable exit was VMware, Inc, an estimated $58.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Boothbay Fund Management opened a new position in Splunk Inc worth $15.3M.
- Boothbay Fund Management's largest Q4 2023 buy was Splunk Inc: 100,578 shares worth $15.3M.
- Boothbay Fund Management added most to US Steel in Q4 2023, an estimated $22.8M increase.
- Boothbay Fund Management's biggest Q4 2023 reduction was Elanco Animal Health, cutting an estimated $18.6M.
- Boothbay Fund Management fully exited VMware, Inc in Q4 2023, selling an estimated $58.4M.
- Boothbay Fund Management's ten largest holdings make up 15% of its $3.92B portfolio in Q4 2023.
- Boothbay Fund Management opened 473 new positions and closed 539 in Q4 2023.
- Boothbay Fund Management's portfolio value fell 6.9% quarter-over-quarter to $3.92B.
Based on Boothbay Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.